Genotype®MTBDRplus and Xpert®MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis : cost analysis in a tertiary referral hospital.

Simple item page
dc.contributor.authorSoares, Valéria Martins
dc.contributor.authorAlmeida, Isabela Neves de
dc.contributor.authorVater, Maria Cláudia
dc.contributor.authorAlves, Suely
dc.contributor.authorFigueredo, Lida Jouca de Assis
dc.contributor.authorScherer, Luciene
dc.contributor.authorKritski, Afranio Lineu
dc.contributor.authorCarvalho, Wânia da Silva
dc.contributor.authorMiranda, Silvana Spindola de
dc.date.accessioned2023-01-17T17:39:04Z
dc.date.available2023-01-17T17:39:04Z
dc.date.issued2020pt_BR
dc.description.abstractIntroduction: The present study sought to assess the mean and activity based cost (ABC) of the laboratory diagnosis for tuberculosis through the application of conventional and molecular techniques—Xpert®MTB/RIF and Genotype®MTBDRplus—in a tertiary referral hospital in Brazil. Methods: The mean cost and ABC formed the basis for the cost analysis of the TB laboratory diagnosis. Results: The mean cost and ABC were US$ 4.00 and US$ 3.24, respectively, for a bacilloscopy; US$ 6.73 and US$ 5.27 for a Lowenstein-Jensen (LJ) culture; US$ 105.42 and US$ 76.56 for a drug sensitivity test (DST)–proportions method (PM) in LJ; US$ 148.45 and US$ 136.80 for a DST–BACTECTM MGITTM 960 system; US$ 11.53 and US$ 9.89 for an Xpert®MTB/RIF; and US$ 84.21 and US$ 48.38 for a Genotype®MTBDRplus. Conclusions: The mean cost and ABC proved to be good decision-making parameters in the diagnosis of TB and MDR-TB. The effective implementation of algorithms will depend on the conditions at each location.pt_BR
dc.identifier.citationSOARES, V. M. et al. Genotype®MTBDRplus and Xpert®MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis: cost analysis in a tertiary referral hospital. Revista da Sociedade Brasileira de Medicina Tropical, v. 53, 2020. Disponível em: <https://www.scielo.br/j/rsbmt/a/6sQTBmPbkDXcLYvBNhjdJmG/?lang=en>. Acesso em: 11 out. 2022.pt_BR
dc.identifier.doihttps://doi.org/10.1590/0037-8682-0175-2019pt_BR
dc.identifier.issn1678-9849
dc.identifier.urihttp://www.repositorio.ufop.br/jspui/handle/123456789/15955
dc.language.isoen_USpt_BR
dc.rightsabertopt_BR
dc.rights.licenseThis is an open access article distributed under the terms of the Creative Commons license. Fonte: o PDF do artigo.pt_BR
dc.subjectMycobacteriapt_BR
dc.subjectMean costpt_BR
dc.subjectActivity based costpt_BR
dc.titleGenotype®MTBDRplus and Xpert®MTB/RIF in the diagnosis of tuberculosis and resistant tuberculosis : cost analysis in a tertiary referral hospital.pt_BR
dc.typeArtigo publicado em periodicopt_BR
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ARTIGO_GenotypeMTBDRPlus.pdf
Size:
916.93 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
DEACL - Artigos publicados em periódicos